Selvita

Selvita is an integrated service company providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development.

The company was established in 2007 and as a Selvita Group of companies currently employs over 750 professionals. At the beginning of 2021, Selvita completed its acquisition of Fidelta – Croatian CRO company. This corporate milestone provides a significant increase in business scale and solid foundations for further growth.

We are headquartered in Krakow, Poland, with a second research site in Poznan, Poland, while Fidelta is located in Zagreb, Croatia. Our foreign offices are located in Cambridge, MA and San Francisco Bay Area, in the US, as well as in Cambridge, UK. Specialising in delivering integrated solutions Selvita has a proven track record of not just providing scientific excellence, but on building long-term partnerships with our clients and playing an active, consultative role in the project execution.